Microneedle Drug Delivery Systems Market to Achieve Significant Growth, Projected to Reach USD 1459.1 Million by 2033 with a CAGR of 6.6%

Microneedle Drug Delivery Systems Market

The microneedle drug delivery systems market. According to the report, the market is set to record a compound annual growth rate (CAGR) of 6.6% from 2023 to 2033. The market size, which is projected to reach USD 768.9 million in 2023, is expected to grow significantly to USD 1459.1 million by 2033.

Innovative technologies called microneedle drug delivery systems use hundreds of microneedles placed on a tiny patch to deliver medication. This method guarantees efficient and painless drug administration by directly delivering medication into the viable epidermis without coming into contact with the dermal layers’ blood vessels and nerves.

The microneedles are formed of a variety of materials and have typical dimensions of hundreds of microns for length, 1 to 50 microns for width at the tip, and 50 to 300 microns for base. These substances include polymers, carbohydrates, silicon, silica glass, and ceramics; each has special qualities that improve the efficiency of microneedle drug delivery systems.

Microneedle technology is becoming more and more popular due to its many benefits, which include less invasiveness, less pain, and better patient compliance. This technology is an essential feature of contemporary medical therapies since it makes administering insulin, vaccinations, and other medicinal chemicals easier.

Request a report sample to gain comprehensive insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2750

Key Takeaways from the Report

• Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
• Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
• Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
• North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
• East Asia is expected to be the fastest-growing regional market during the next decade.

“Companies operating in the market are leaving no stone unturned to introduce innovations. Some have even tied up with leading solutions provider to commercialize their innovations once approved. This is expected to pave way for the market’s growth in the near future” said a lead Analyst at FMI.

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-2750

 Key Players:

3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

Consolidating their positions through mergers, acquisitions and new product launches, global microneedle drug delivery systems market players rely heavily on new product innovation and differentiation for gaining an edge over their competitors.

The market is poised to grow during the forecast period owing to the increasing cases of diseases and needle phobia among patients. However, changing regulatory dynamics are expected to affect the growth of microneedle drug delivery systems market in the future.

For instance, Zosano Pharma’s clinical trial of zolmitriptan with microneedle drug delivery system was stopped by U. S. Food and Drug Administration because inconsistencies were found in the drug delivery.

To Know More about Heat induction Cap liner Market:

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global microneedle drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on microneedle drug delivery systems market on the basis of product type such as solid microneedles, hollow microneedles and dissolving microneedles. Based on end-user such as hospitals, ambulatory centers, specialty clinics, academic institutes and research institutes across seven major regions

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/2750

Key Segments

Product Type

• Solid Microneedles
  • Silicon
  • Metal
  • Polymer
• Hollow Microneedles
• Dissolving Microneedles

End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Academic Institutions
• Research institutes

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube